GLP-1 contributes to myriad of metabolic effects, including insulin secretion, beta cell proliferation, slowing of gastric emptying and increased satiety; all are desirable features of type 2 diabetes therapy [1]–[3]. The gene discussed is INS; the disease is type 2 diabetes mellitus.